Category: HeartWare International Inc.
HeartWare International has issued an urgent recall for certain computerized controllers for its ventricular assist devices over concerns that they may malfunction and cause the heart pump to stop.
HeartWare International (NSDQ:HTWR) has issued an urgent recall for certain computerized controllers for its ventricular assist devices over concerns that they may malfunction and cause the heart pump to stop.
HeartWare International's preliminary sales numbers for the 4th quarter beat expectations as it launches a thoracotomy trial for its implantable heart pump.
Thoratec's 3rd-quarter earnings plunge nearly 85% as sales decline more than 16%, raising fears that the left ventricular-assist device market is in a slump that could persist into 2015.
Thoratec (NSDQ:THOR) yesterday said its 3rd-quarter profits plunged some 85%, missing forecasts, and dimmed its outlook for the rest of the year.
HeartWare posts narrowed 3rd-quarter losses thanks to increased sales of its implantable heart pumps in the U.S.
HeartWare International (NSDQ:HTWR) yesterday reported narrowed 3rd-quarter losses and significantly higher revenues, boosted by a 39% jump in U.S. sales of its implantable heart pumps.
HeartWare International names Dr. Katrin Leadley to be its new chief medical officer following the retirement of Dr. David Hathaway.
, eLux Medical
, HeartWare International Inc.
, NxStage Medical Inc.
, Revolutions Medical Corp.
, Terumo Corp.
, X2 Biosystems
, AngioDynamics Inc.
A voluntary recall initiated yesterday pushes HeartWare shares down today, despite 2nd-quarter result that crushed expectations on Wall Street.
UPDATED July 31, 2014 with additional comment on recall.
FDA regulators publish a formal warning against HeartWare, for which the company had advised shareholders to be on the lookout.
FDA inspectors finally revealed the anticipated warning letter against Massachusetts-based medical device maker HeartWare (NSDQ:HTWR), chiding the company for manufacturing violations.